NanoVibronix Appoints New CFO and Directors

Ticker: FEED · Form: 8-K · Filed: Jul 30, 2025 · CIK: 1326706

Nanovibronix, Inc. 8-K Filing Summary
FieldDetail
CompanyNanovibronix, Inc. (FEED)
Form Type8-K
Filed DateJul 30, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: leadership-change, board-of-directors, cfo-appointment

Related Tickers: NVBX

TL;DR

NVBX shakes up leadership: new CFO Jonathan Lerman, directors David Smith & Robert Smith join the board.

AI Summary

NanoVibronix, Inc. announced on July 24, 2025, changes in its board of directors and officer appointments. Specifically, the company elected two new directors, Dr. David L. Smith and Mr. Robert J. Smith, to its Board of Directors, effective immediately. Additionally, Mr. Jonathan S. Lerman was appointed as the new Chief Financial Officer.

Why It Matters

Changes in key leadership roles like CFO and board composition can signal strategic shifts or governance updates that may impact the company's future direction and investor confidence.

Risk Assessment

Risk Level: medium — Leadership changes, especially at the CFO level and board composition, can introduce uncertainty regarding future strategy and execution.

Key Players & Entities

  • NanoVibronix, Inc. (company) — Registrant
  • Dr. David L. Smith (person) — Newly elected Director
  • Mr. Robert J. Smith (person) — Newly elected Director
  • Mr. Jonathan S. Lerman (person) — Newly appointed Chief Financial Officer
  • July 24, 2025 (date) — Date of earliest event reported

FAQ

Who were the newly elected directors for NanoVibronix, Inc.?

Dr. David L. Smith and Mr. Robert J. Smith were elected as new directors.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on July 24, 2025.

Who has been appointed as the new Chief Financial Officer?

Mr. Jonathan S. Lerman has been appointed as the new Chief Financial Officer.

What is the state of incorporation for NanoVibronix, Inc.?

NanoVibronix, Inc. is incorporated in Delaware.

What is the principal executive office address for NanoVibronix, Inc.?

The principal executive office is located at 969 Pruitt Ave, Tyler, Texas 77569.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 30, 2025 by Dr. David L. Smith regarding NanoVibronix, Inc. (FEED).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.